Skip to main content
Home
  • About
    • About SGC
    • Members & Technology Partners
    • Governance
    • Open Science
    • Impact
    • SGC Gender Equality Plan
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
        • Legacy Protein Protocols
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Protein Contribution Network
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us
  • Home
  • About
    • About SGC
    • Members & Technology Partners
    • Governance
    • Open Science
    • Impact
    • SGC Gender Equality Plan
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
        • Legacy Protein Protocols
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Protein Contribution Network
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us

Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space.

  • Read more about Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space.

The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines.

  • Read more about The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines.

Prediction and Validation of a Protein's Free Energy Surface Using Hydrogen Exchange and (Importantly) Its Denaturant Dependence.

  • Read more about Prediction and Validation of a Protein's Free Energy Surface Using Hydrogen Exchange and (Importantly) Its Denaturant Dependence.

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.

  • Read more about Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.

Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2.

  • Read more about Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2.

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.

  • Read more about TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.

Design of a Potent TLX Agonist by Rational Fragment Fusion.

  • Read more about Design of a Potent TLX Agonist by Rational Fragment Fusion.

Structural Aspects of LIMK Regulation and Pharmacology.

  • Read more about Structural Aspects of LIMK Regulation and Pharmacology.

Autoantibodies against Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from an Australian Single-Center Cohort.

  • Read more about Autoantibodies against Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from an Australian Single-Center Cohort.

Aurora Kinase A Is Involved in Controlling the Localization of Aquaporin-2 in Renal Principal Cells.

  • Read more about Aurora Kinase A Is Involved in Controlling the Localization of Aquaporin-2 in Renal Principal Cells.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • Page 185
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

A global public-private partnership that supports the discovery of new medicines through open-access research.

  • Careers
  • Contact Us

Structural Genomics Consortium. Registered charity 1097737 (England and Wales). Registered company limited by guarantee 04714553 (England and Wales). Except where otherwise noted, all content on this site is licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

Be the first to know with our SGC Bulletin!

Want to know what we are up to?
Leave your e-mail address below and you will receive a monthly source of SGC news from across our six research sites.

SIGN UP FOR OUR NEWSLETTER

Footer

  • Privacy Policy
  • Legal Information
  • Contact Us
  • Login